Will Sanofi’s Dengvaxia Woes Spiral Beyond The Philippines?

Sanofi appears to be under mounting pressure in the Philippines over deaths allegedly linked to its dengue vaccine and after declining to refund costs of the doses already used in the Southeast Asian nation’s vaccination plan. Whether or not the goings on could have a domino effect could be crucial for the product’s future.